Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Each trial included at least two treatment arms/groups: one group received tirzepatide either as monotherapy or in combination with other drugs, and the other group was given a placebo or another active comparator, either alone or in combination with other drugs
Petrikaite, V., DAvanzo, N., Celia, C
God bless you
In addition, we also found that the clinical rationale and protocol design of the TEXAIS (Treatment With Exenatide in Acute Ischemic Stroke) trial (Trial registration: ClinicalTrials.gov/ANZCTR NTA1127 and ACTRN12614001189617) (108, 109)
As expected
US$ 22.62
US$ 27.11
US$ 28.07
US$ 29.52
